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a b s t r a c t
The nature and the purpose of the ECRIN Data Centre Certiﬁcation Programme are summarised, and a
very brief description is given of the underlying standards (129 in total, divided into 19 separate lists).
The certiﬁcation activity performed so far is described. In a pilot phase 2 centres were certiﬁed in 2012.
Calls in 2014 and 2015 resulted in a further 8 certiﬁed centres, with 2 certiﬁcations still in progress, and
the 2016 call has generated several additional applications. The impact and beneﬁts of the programme
are listed, divided into a) the effects of the introduction of the standards, b) the effects of the certiﬁcation
programme in general, and c) the effects of the certiﬁcation programme on individual units. The dis-
cussion emphasises the generally positive impact of the programme so far but stresses the need to better
clarify the perspective and role of the programme.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
The European Clinical Research Infrastructure Network, ECRIN,
is a non-proﬁt organisation which aims to facilitate multi-national
clinical research across Europe. It does that by providing a wide
variety of tools and services, as well as informational support, and
by implementing programmes promoting greater consistency and
quality in clinical trial management [1].
Since 2013 ECRIN has been one of several ‘ERIC's, i.e. a European
Research Infrastructure Consortium, funded by direct contributions
from the governments of the ECRIN member countries (which are
not restricted to member states of the EU e the European Union).
ECRIN ﬁrst developed, however, as an infrastructure project within
the EU's centrally funded research programmes, Framework
Programmes (FP) 6 and 7.
In 2009, within FP7, an ECRIN workgroup charged with devel-
oping support for data management within clinical trials units
carried out a survey of information technology (IT) and data man-
agement practices in non-commercial trial units across Europe.
This conﬁrmed the anecdotal evidence, of considerable heteroge-
neity in both systems and practices. Many different software
products for data management were being used in clinical trials
units, and these included many proprietary, locally developed so-
lutions rather than professional products [2]. Deﬁcits in the quality
of data management were also observed in some units, including
missing SOPs (standard operating procedures) and limited valida-
tion and change management, of both underlying systems and in-
dividual trial databases.
Most academic centres are constrained by limited human and
ﬁnancial resources and, historically, had sometimes found it difﬁ-
cult to provide levels of IT and data management which were fully* Corresponding author.
E-mail address: christian.ohmann@med.uni-duesseldorf.de (C. Ohmann).
Contents lists available at ScienceDirect
Contemporary Clinical Trials Communications
journal homepage: www.elsevier .com/locate/conctc
http://dx.doi.org/10.1016/j.conctc.2017.02.005
2451-8654/© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Contemporary Clinical Trials Communications 5 (2017) 153e159
and formally compliant with Good Clinical Practice (GCP), espe-
cially in the context of complex international trials. With the
stimulus of the 2001 European Directive [3] and the consequent
national legislation, academic trials units were certainly developing
their quality management systems, including in data management.
But one crucial problem was that there was no public, freely
available and widely accepted interpretation of what GCP compli-
ance meant for IT and data management in practical, concrete
terms.
For that reason ECRIN decided, in the framework of the FP7
ECRIN project, to develop a set of quality standards or re-
quirements. Taken together thesewould describe GCP-compliant IT
and data management, with the emphasis on pragmatic measures
that were feasible for non-commercial units. The standards were to
be freely available, and were intended to be used for, amongst other
things, quality management, validation, preparation of audits, and
staff training.
Furthermore, ECRIN would use these requirements as a basis for
selection and certiﬁcation of recognised ‘ECRIN data centres’, units
that could demonstrate compliance with the ECRIN standards and
that could therefore be used with conﬁdence within ECRIN sup-
ported programmes. As a consequence, after the ﬁrst version of the
standards were developed from 2009 to 2011, the ECRIN data
centre certiﬁcation programme was launched in 2011 (initially as a
pilot), and it has been successfully implemented though yearly calls
(2014, 2015, 2016).
The aims of the certiﬁcation programme, and the standards that
support it, have therefore always included the two speciﬁc aspects
below, within the more general goal of explicitly setting out data
management standards for clinical research:
a) to audit individual units against the standards, to conﬁrm their
ability to provide compliant, effective and efﬁcient data man-
agement services for controlled clinical trials, and for ECRIN-
supported multi-national trials in particular,
b) to provide a clear interpretation of regulatory and good practice
requirements, in the particular context of non-commercial trials
units in Europe, and so act as a practical guide to establishing
and managing high-quality data management services.
In this paper we ﬁrst summarise the methods used to bring
about those aims, with an outline of both the standards and the
ECRIN data certiﬁcation programme to date. The results of the
certiﬁcation programme are then described, and the weaknesses
and strengths of the programme discussed.
2. Methods
2.1. Developing the ECRIN data centre standards
The initial version of the standards were assembled by ECRIN
domain experts from a wide variety of trials units and countries,
using both face to face meetings and amodiﬁed Delphi process. The
starting point was GCP, but a variety of international, European and
national regulations and guidelines were also considered, dis-
cussed, distilled, adopted and adapted. These included:
 EU Directives for the implementation of GCP: 2001/20/EC, EU
Directive 2005/28/EC, EU Directive 95/46/EC
 Computerized Systems, EudraLex - Volume 4, Annex 11
 EMEA Reﬂection paper on expectations for electronic source
documents used in clinical trials
 Good practice for computerized systems in regulated GXP en-
vironments, PIC/S Inspectors Guide
 Good Automated Manufacturing Practice (GAMPR) Version 5 of
the International Society for Pharmaceutical Engineering,
 FDA: Guidance for Industry: Computerized Systems Used in
Clinical Trials and 21 CFR Part 11
 ISO 27001 Information Security Management - Speciﬁcation.
These documents stimulated discussion and ideas, and some-
times directly suggested a requirement statement. But in general
the ECRIN working group concentrated on deﬁning standard re-
quirements that, whilst certainly in line with the documents listed
above, and with the principles of GCP in particular, reﬂected the
special needs of data centres in non-commercial clinical trials units.
Version 1.0 of the standards was produced in 2010. The process of
creating them is described in more detail in Ref. [4].
In fact the 2011 pilot certiﬁcation programme showed that the
original requirements were too numerous and over complicated,
being divided into both ‘essential’ and ‘best practice’ standards. The
list was substantially simpliﬁed in 2012, with only the ‘essential’
standards retained. The revision process, also carried out by a group
of ECRIN domain experts, and the 139 standards that remained
after it, are described in Ref. [5]. The other signiﬁcant change post-
pilot was the introduction of paragraphs of explanatorymaterial for
each standard: to try and ensure a consistent interpretation of the
requirements, to give examples and further practical guidance, and
to indicate the evidence that would normally be expected to sup-
port a claim to compliance.
Feedback from the audits in 2014 generated a further review
process in 2015, but this time the version that emerged (v3.0)
exhibited a relatively small level of consolidation, with the 139
standards becoming 129. Much of the explanatory material was
extended, however, because of:
a) A variety of requests for further clariﬁcation and guidance, for
instance about system validation, and
b) The increased use by trials units of distributed IT infrastructures,
e.g. the growing use of externally hosted database systems. It
was necessary to clarify how the standards could be applied to
both externally and locally hosted services.
Version 3.0 of the standards can be downloaded at [6]. Further
reviews are likely in the future but we hope changes in the stan-
dards themselves will be relatively minor, though the explanatory
material may continue to expand.
2.2. The current ECRIN standards
The 129 listed standards, or ‘requirements for data centre cer-
tiﬁcation’, are divided into 19 separate lists, some focused on IT,
some mainly concerned with data management, and some that
deal with both (see Fig. 1).
In terms of the traditional framework used for quality measures
in health care, Donabedian's triad of structure, process and
outcome measures [7], the ECRIN requirements are very largely
(about 80%) focused on process, with the remainder dealing with
structure. Measuring outcome measures was seen as too difﬁcult
within a short term audit.
The expectation is that most of the relevant structural compo-
nents, for instance, a secure network, external ﬁrewalls, a clinical
data management system (CDMS) that is compliant with GCP, and
some form of treatment allocation system will be present. This
assumption has been borne out by the audits e the structural
components are almost always in place and modern CDMS systems
are indeed ‘technically compliant’, for instance they provide audit
trails, logical access controls, etc.
But technical compliance is just that e it provides the potential
C. Ohmann et al. / Contemporary Clinical Trials Communications 5 (2017) 153e159154
but not the proof of actual compliance. The focus is therefore very
much on the quality systems (SOPs etc.), processes, procedures and
people that the centre puts around these components to ensure
good practice, and e critically e the demonstration of their use in
practice.
2.3. The process of certiﬁcation
Yearly (in May) a call for certiﬁcation of data centres is launched
on the ECRIN website with a deadline for application at the end of
August. The call is currently restricted to academic trial units from
national scientiﬁc networks belonging to ECRIN-ERIC members
(Germany, France, Italy, Spain, Portugal, Hungary, Norway). The
candidates centres are proposed by the national scientiﬁc networks
in each country.
Certiﬁcation is based on an on-site audit of the centres' data
management and IT services against the standards, carried out over
two to three days by a team of auditors, all staff with substantial
experience in trials IT, data management or quality assurance. Au-
dits are carried out in English but at least one of the audit team is a
native speaker in the centre's working language.
The auditors do not make the certiﬁcation decision. Instead they
produce reports for the ECRIN Independent Certiﬁcation Board, a
body of currently 7 senior professionals in clinical trials manage-
ment nominated by ECRIN's senior scientiﬁc group, the Network
Committee. It is the Certiﬁcation Board that makes the award de-
cision, based on the auditors' reports and any further explanatory
information made available by the unit themselves.
The Board also has the discretion to postpone certiﬁcation, to
give a centre the opportunity to correct identiﬁed issues, and will
then request either documentary evidence of the changes or a later
re-audit to verify that the corrective action has been successful.
Certiﬁed centres are listed on the ECRIN webpage. The costs related
to audits (approximately V6000) and the work of the Certiﬁcation
Board are covered by the ECRIN-ERIC budget.
Certiﬁcation, once awarded, lasts for 4 years. The re-certiﬁcation
process has been designed to be risk-based, so that the extent and
duration of any re-audit will be based on a prior assessment of the
changes that have occurredwithin the unit in the intervening years.
2.4. The certiﬁcation programme, to mid-2016
As a result of a pilot phase 2 centres were certiﬁed in 2012 (KKS
Düsseldorf, Germany; Uppsala Clinical Research Centre, Sweden).
Thereafter three regular calls have been launched in 2014, 2015 and
2016 (ongoing), with most of the audits taking place at the end of
each year or the beginning of the next.
Six units applied in 2014, of which 5 are now certiﬁed (EUCLID,
Bordeaux, France; The clinical trial unit, Freiburg, Germany; Mario
Negri, Milano, Italy; GIMEMA, Roma, Italy; AIBILI, Coimbra,
Portugal) with one certiﬁcation remaining in progress. In 2015 four
applications were received. Three of the units are certiﬁed (UPCET,
Lyon, France; IZKS Mainz and KKS Marburg, Germany), with certi-
ﬁcation in progress for the fourth. A summary of the certiﬁcation
programme is given in Table 1.
Of the 10 units now certiﬁed, only three received certiﬁcation
immediately. The other seven ﬁrst required some corrective action
and either the production of documentary evidence of changes (in
2 cases) or a re-audit (in 5 cases). This indicates that the ECRIN
standards are attainable, but certainly not easy, which seems
wholly appropriate for standards designed to indicate high quality
IT and data management.
3. Results
The current small number of ECRIN certiﬁed trials units, after
just two completed rounds of audits (n ¼ 10) and the still limited
number of new multinational clinical trials supported by ECRIN
(e.g. 16 in 2016), means evaluation of the impact of the program is
conﬁned to relatively local or short acting effects. Nevertheless, it is
possible to already identify three areas where such effects are
visible. The ﬁrst is concerned with the development and dissemi-
nation of the ECRIN data centre standards, the second with the
certiﬁcation process itself, and the third is the effect on the units that
have gone through certiﬁcation.
Fig. 1. The current ECRIN standards. Numbers in brackets refer to the number of standards under each heading. (CDMA ¼ Clinical data management application, the speciﬁc
database system developed for an individual trial, including the study speciﬁc eCRFs, navigation and check logic etc.)
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3.1. Beneﬁts associated with the certiﬁcation standards
Although IT and data management are services provided to
support research, and not ends in themselves, they can cause
considerable problems to trial units and even invalidate results if
not carried out properly. By raising awareness of key IT/data
management issues, and by identifying and promoting good prac-
tice, the standards therefore have an important role in the more
general drive to reduce wastage in research [8].
The standards also represent the ﬁrst time that the often vague
statements about IT and data management that are found in GCP
and other regulatory material have been turned into detailed and
pragmatic statements of good practice, tailored to the resources
available within not-for-proﬁt trials units. Their perceived useful-
ness is reﬂected in some countries by their incorporation into na-
tional quality initiatives and documentation:
a) In Switzerland, the Swiss Clinical Trials Organisation devel-
oped GCP-compliant guidelines for data management pro-
cesses in clinical study management closely following the
ECRIN standard and incorporated it into their 'Guidelines for
Good Clinical Practice' document, making explicit reference
to their origin within ECRIN [9].
b) In France, the standards were ﬁrst translated and then inte-
grated into the “Good Professional Practices” manual for
French Clinical Investigation Centres. The translation was
published in the journal Therapie [10].
c) In Germany, initiated by the German clinical trials network
(KKSN) and funded by the German Ministry for Education
and Research (BMBF) ﬁve German trial units were selected
by independent reviewers to prepare for the certiﬁcation as
ECRIN data centres. The objective of the grant was to
implement the ECRIN requirements in these centres. In fact
four German centres have now been certiﬁed, and two more
have applied as part of the 2016 call.
d) In Asia, a collaboration between ECRIN and the Japanese
Academic Research Organisation (ARO) network is currently
being explored. As a ﬁrst step the ECRIN standards (version
3.0) have been translated into Japanese. More details were
discussed in a series of workshops (Summer 2016) with
training for Japanese auditors arranged for February 2017.
In other countries, for example the UK, the standards have been
extensively discussedwithin the national networks, and some units
have decided to use them as deﬁnitions of good practice, for
instance in the context of self-assessment.
The standards have also been seen as a direct source of expert
guidance in clinical trial IT and data management, as evidenced by
the steadily rising number of ad hoc queries coming into ECRIN,
about the meaning and application of the standards or IT and data
management in general. The data management standards have
been seen as a useful model for similar initiatives, particularly
within other areas of ECRIN. A similar 'standard approach' is
currently being considered in nutrition research, in monitoring and
in pharmacovigilance.
Reviewing the standards to keep them relevant has helped to
raise issues and stimulated debate about ongoing developments in
practice. For instance the need to address the increased use of
external hosting e e.g. with 'cloud' computing e led ECRIN to
initiate a workshop with experts in the ﬁeld, to try and clarify the
risks and beneﬁts associated with such usage [11].
3.2. Beneﬁts associated with the certiﬁcation programme in general
The most obvious beneﬁt has been to identify and/or promote
data centres with high quality practice in member countries of
ECRIN. This is the prime purpose of the certiﬁcation programme,
and (while the process has only just begun) the certiﬁcation pro-
cess does seem to genuinely differentiate and identify high quality
IT and data management practice in trials units. Once publicly
identiﬁed, certiﬁed centres can take on a mentor/demonstrator
relationship with centres under development. In countries where
there already is a mature network of trial units this may be less
important (inter-unit relationships can often be competitive rather
than co-operative) but in countries with a smaller network of
centres having a recognised centre of excellence is seen as a key
component in developing that network.
The certiﬁcation process continually tests the standards in the
real world e and ensures that they have real relevance and are not
just an academic or static set of suggestions. The audit process is
itself a dialog, and the feedback received from the units helps to
sustain the review of standards and maintain their relevance. As
assessed in a survey, the certiﬁcation process also raises the
knowledge and skills of the auditor group e as one auditor said “By
checking (our) own processes against the ECRIN standards you are
able to ﬁnd deﬁciencies and by reading the Explanation and Elab-
oration you are able to ﬁnd possible solutions”, and several auditors
have made similar remarks. The auditors are experienced and often
inﬂuential staff, so this not only helps to raise general awareness of
good IT and data management but also helps to disseminate it
through the wider clinical trial community.
A process of recognition of the programme by regulatory bodies
has begun. The programme has been presented to the EMA GCP
Inspectors Working Group (December 2015) and to a representa-
tive of the German Expert Group of Inspectors dealing with Com-
puter based Systems (August 2015).
3.3. Beneﬁts for the trial units certiﬁed
The audited units have all given positive feedback about the
audit process itself. Although they need to prepare for the audit
they receive in return (effectively) 2e3 days of free consultancy
from experienced staff. Even the best centres can obtain beneﬁt
from inspection of their processes and resulting discussion, and we
know, from feedback received indirectly, if informally, through the
national networks, the centres themselves conﬁrm this. The audits
often accelerate developments already planned or being consid-
ered, sometimes making it easier for resources to be found, for
example from a parent organisation. There is rarely a disagreement
on the auditors' ﬁndings of non-compliance e more normally the
unit agrees there is a deﬁciency but explains that they have not yet
had a chance to deal with it. The certiﬁcation process itself can be a
powerful incentive to get these issues resolved.
Successful certiﬁcation brings with it afﬁliate membership of
ECRIN, through a framework contract with the certiﬁed data centre.
This in turn makes it much easier to include the unit (as a linked
third party) in Horizon 2020 bids and other funding initiatives
where ECRIN is a partner. Until recently, this has been of relatively
limited importance, partly because certiﬁcation has been limited to
Table 1
Status of certiﬁcations for ECRIN data centre certiﬁcation program.
Call Applications Audits Re-audits Certiﬁcation
Pilot 2 2 (in 2011) 2 (in 2012) 2 (in 2012)
2014 6 6 (2 in 2014,
4 2015)
3 (2 in 2015,
1 to do)
5 (4 in 2015,
1 in 2016)
2015 4 4 (4 in 2016) 2 (1 in 2016,
1 to do)
3 (3 in 2016)
2016 4 4 in early 2017 2 in 2017 e
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only a few units and partly because the framework contracts only
recently started to be implemented. As a consequence, certiﬁed
units have only been involved in a few EU FP7/H2020-funded
projects so far (6 ECRIN studies supported by 3 certiﬁed data cen-
tres), but the hope and expectation is that this will increase in the
coming years due the framework contracts between ECRIN and the
certiﬁed data centres.
4. Discussion
The audit based certiﬁcationmechanism used by ECRIN is one of
several approaches and initiatives that have been taken to improve
quality within non-commercial clinical trials units. Each European
country has its own ofﬁcial regulatory and inspection regime of
course, but anecdotal evidence indicates that the time and re-
sources these have available to examine academic research units (if
they are not Phase I units) is highly variable. In some countries
inspection of such units occurs regularly, in others as necessary, on
the basis of a risk assessment, and in others it seems to hardly occur
at all.
4.1. Promoting quality through training
One approach to promoting quality focuses on training and
supervision of staff. Several organisations offer training courses
with certiﬁcation for individual professionals in clinical data
management. Examples are the Society for Clinical Data Manage-
ment, a non-proﬁt, international organisation, which established
the Certiﬁed Clinical Data Manager program for clinical data
managers [12], and Barnett International, a for-proﬁt organisation
in clinical research training, that provides a 30-Hour Clinical Data
Management On-Boarding Program with certiﬁcation [13].
The ECRIN standards include requirements that policies for
initial and continuing training (of IT and data management staff)
are in place, and that training should be clearly recorded and
regularly reviewed on an individual basis. They do not however,
stipulate any particular training course for any role, recognising
the very wide range of provision that is available, including locally
created courses and support (though there is an expectation that
fundamental issues like GCP and data protection are covered, by
both initial and continuing training programmes). The proper
preparation of personnel is a prerequisite for GCP compliance, so
the focus is on the unit demonstrating that it can identify training
needs, manage the training processes that follow, and maintain
the required levels of competence. Speciﬁc training programmes
are seen as complementary to the more general ECRIN
requirements.
4.2. Registration
Another approach to identifying quality is by using self-
assessment and self-reporting, against a pre-deﬁned set of
criteria. This is the method used in the UK, within its registration
scheme for non-commercial clinical trial units. Registration brings
both reputational and ﬁnancial rewards, so the trials units are
highly motivated to seek registered status. Within the registration
process, an international review panel assesses compliance with
the stipulated competencies every 5 years. In a recent report, im-
provements in IT systems and hosting of clinical trial databases
were claimed as a result of the registration process [14]. ECRIN
considered a similar methodology for promoting quality but
decided that the reliance on self-reporting, though a good initial
step and certainly cheaper to implement than an audit based sys-
tem, would give insufﬁcient credibility to the certiﬁcation decision.
4.3. Other audit based systems
In other countries, external audits are used. In Germany, for
example, the membership of an academic trial unit in the national
scientiﬁc network (Network of the Koordinierungszentren für Kli-
nische Studien (KKSN)) is based on a successful external audit, that
includes DM and IT procedures [15].
A voluntary certiﬁcation scheme for commercial and non-
commercial phase I units was created by the MHRA in the UK as
a consequence of the TGN1412 incident, in which several healthy
volunteers in a Phase I study in 2006 sufferedmultiple organ failure
[16]. Version 3 of their requirements for accreditation was pub-
lished in October 2015, though the focus is verymuch, as onewould
expect, on patient safety. The scheme is based on successful in-
spection against the 20 listed requirements.
The British Standards Institution (BSI) and the Alliance for
Clinical Research Excellence and Safety (ACRES), in the US,
announced in early 2016 an initiative to develop global standards of
excellence for clinical research sites (rather than trials units) [17].
The intention is to create “a comprehensive set of standards
covering … patient and subject engagement and protection, site
personnel, research integrity, facilities, information systems and
data management, management and administration as well as
quality management”.
According to the web site: “These standards and derived metrics
will enable an innovative ‘dynamic accreditation’ process that
automatically monitors operational data in real time to continu-
ously improve site and system performance, beneﬁtting stake-
holders while minimizing research site burdens.” It is unclear what
this will mean in practice but the approach is an interesting one and
could be very relevant to the ECRIN certiﬁcation programme in the
future, especially if that extends beyond IT and datamanagement to
other areas (e.g. pharmacovigilance, monitoring).
4.4. Using ISO standards
Formal certiﬁcation, e.g. using ISO standards, is another
approach (and several trials units have or are investigating certiﬁ-
cation of their quality systems with ISO 9001). Within the ECRIN
certiﬁcation scheme we examined the ISO 27000 series in partic-
ular and borrowed some concepts from ISO 27001 (dealing with IT
security management), for instance the need for an ongoing secu-
rity management system [18].
Althoughwe acknowledge the importance and usefulness of the
ISO 27000 family of standards, we decided that they were not al-
ways well adapted to relatively small organisations such as aca-
demic trial units, and felt that the lack of freely available supporting
tools and services would also be a problem for academic units
trying to develop compliance with the ISO standards. In addition a
decision to seek ISO certiﬁcation, or not, would most often be taken
at an institutional level and be outside the control of a trials unit.
We therefore did not incorporate ISO certiﬁcation, in any form, into
the ECRIN standards.
We have also discussed developing the ECRIN certiﬁcation
process into an ISO or similar formal scheme. This offers the po-
tential of increased credibility but e certainly to begin with e the
additional costs and administrative overhead incurred (including
the costs of having ECRIN accredited as an ISO certifying organi-
sation), and the increased costs of carrying out each unit
C. Ohmann et al. / Contemporary Clinical Trials Communications 5 (2017) 153e159 157
certiﬁcation for ECRIN, were seen as prohibitive. It may be, how-
ever, that after some years' operating the certiﬁcation scheme, this
question could be usefully re-examined.
4.5. The ECRIN approach e audits against public standards
In the end ECRIN decided to choose a ‘middle way’ and establish
an audit based certiﬁcation scheme using its own standards. We
believe this has greater credibility than a system based solely on
self-assessment, but it avoids the substantial costs of working
against ISO standards.
By using public, published standards the certiﬁcation pro-
gramme is far more transparent and understandable than a scheme
based upon the private thoughts and concerns of individual 'expert'
auditors. We believe this approach also makes the audit process
much less intimidating and more productive. By using continuous
review of public standards the programme not only ensures the
ongoing relevance of those standards, it also helps to characterise
and disseminate good practice within the clinical trials community
generally, and to identify new issues that are appearing in practice,
where trials units are often looking for information and support.
4.6. Future plans
Having said that, it is true that we are suffering from a 'critical
mass' effect. Certiﬁcation needs to be widespread enough for the
trials community as a whole to understand it, to see that it has been
accepted as valid by key stakeholders, and for the beneﬁts of cer-
tiﬁcation to be clear. The certiﬁcation programme has not yet
reached that critical mass. The key will be to continue to build up
the numbers of certiﬁed units and at the same time continue to
develop, and publicise, the strengths and positive effects of the
programme [19].
Exactly howmany certiﬁed data centres are needed is a question
that has been debated often within ECRIN but as yet is not fully
resolved. One viewpoint is that only a limited number of certiﬁed
centres are necessary to actually support ECRIN services in multi-
national clinical trials. This argument is based on the number of
ECRIN supported studies and the number of requests for data
management services. The alternative view is that certiﬁcation
should be widespread, as part of the drive to increase the capacity
and quality of clinical research in Europe on a wider scale.
It may be that a single pan-European approach is not possible,
because of different strategies and available resources in different
member states. For example, countries with many large developed
units (e.g. Germany) may prefer to qualify a substantial number of
data centres, whereas those with fewer and/or newer research
centres (e.g. Portugal) might want only a few dedicated centres to
be certiﬁed, with these then providing data management services
to other clinical trial units in their country. In some countries,
where data management is currently outsourced to commercial
companies, we may need to consider making certiﬁcation available
to CROs.
Currently, the programme is restricted to ECRIN ERIC member
countries and ﬁnanced by the ECRIN ERIC budget. To broaden the
certiﬁcation programme and to increase awareness and acceptance
by the scientiﬁc community, the plan is to make certiﬁcation
available to ECRIN-ERIC ‘observer’ countries in 2017, although a
not-for-proﬁt charge will be made. Currently ECRIN is planning
further meetings and discussions to establish the next steps for the
certiﬁcation programme, and to clarify the best ways in which
ECRIN can continue to promote quality in clinical research.
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